SONM
DNA X, Inc.
NASDAQ · Technology · Communication Equipment · US
$3.24
+0.68%Year over year
Reported trailing growth
- Revenue
- —
- EBITDA
- +90.6%
- EBIT
- +86.2%
- EPS
- +93.3%
- Free cash flow
- +25.4%
- Operating cash flow
- +25.3%
Forward estimates
Based on analyst estimates
- Revenue
- +359.7%
- EBITDA
- +794.5%
- EPS
- +879.5%
Three-year CAGR
- Revenue
- -100.0%
- EBITDA
- +92.7%
- EBIT
- +83.9%
- Net income
- +38.6%
- EPS
- +77.7%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026